Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VEDROP in Familial Hypocholesterolemia with Chylomicron Retention
NCT01457690Phase 3Completed
- Sponsor
- Hospices Civils de Lyon
- Start
- Oct 2011
- Primary completion
- Aug 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of tocofersolan in chylomicron retention disease (CRD), sponsored by Hospices Civils de Lyon. Started Oct 2011; status: completed.
02
Drugs
tocofersolan
03
Conditions
chylomicron retention disease (CRD)
Beyond the preview
Go deeper on NCT01457690.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01457690.